Results for tag: "Malignant Hematology"

Malignant Hematology is a subspecialty of Hematology that focuses on the diagnosis and treatment of blood cancers, such as leukemia, lymphoma, and myeloma. It also includes the management of other hematologic malignancies, such as myeloproliferative neoplasms and myelodysplastic syndromes. Treatment options for malignant hematology include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies. The malignant hematology market is driven by the increasing prevalence of blood cancers, the development of new treatments, and the rising demand for personalized medicine. Additionally, the increasing focus on early diagnosis and the availability of advanced diagnostic technologies are expected to drive the market. Some companies in the malignant hematology market include Novartis, Celgene, Amgen, Gilead Sciences, and Bristol-Myers Squibb. Show Less Read more